Načítá se...
Evolving Treatment Paradigms in Non-clear Cell Kidney Cancer
With no therapy specifically approved for non-clear cell cancers of the kidney, this disease remains an orphan site. Clear cell renal cancers (ccRCC) have seen a flurry of activity with multiple agents gaining Food and Drug Administration (FDA) approval in recent years. Simultaneously, non-clear cel...
Uloženo v:
| Vydáno v: | Curr Treat Options Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6865068/ https://ncbi.nlm.nih.gov/pubmed/29368112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-018-0521-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|